Pax3 is an evolutionarily conserved transcription factor that plays a major role in a variety of developmental processes. Mutations in Pax3 lead to severe malformations as seen in human Waardenburg syndrome and in the Splotch mutant mice. The transcriptional activity of Pax3 was recently shown to be repressed by Daxx whereas the oncogenic fusion protein Pax3-FKHR is unresponsive to this repressive action. Here we demonstrate that Daxx-mediated repression of Pax3 can be inhibited by the nuclear body (NB)-associated protein PML. Interestingly, this suppression of Daxx properties correlates with its recruitment to the NBs. Factors such as arsenicals and interferons that enhance NB formation, trigger both the targeting of Daxx to these nuclear structures and the relief of the repressive activity of Daxx. Conversely, lack of structurally intact NBs profoundly impairs Pax3 transcriptional activity, likely by increasing the pool of available nucleoplasmic Daxx. Moreover, a PML mutant that can not be modi®ed by the ubiquitin-related SUMO-1 modi®er is no more able to interact with Daxx. Consistently, such a mutant fails both to inhibit the Daxx repressing eect on Pax3 and to induce its accumulation into the NBs. Taken together, these results argue that SUMO-1 modi®ed PML can derepress Pax3 transcriptional activity through sequestration of the Daxx repressor into the NBs and suggest a role for these nuclear structures in the transcriptional control by Pax proteins. Oncogene (2001) 20, 1 ± 9.
Introduction
Pax3 is expressed early during embryonic development in spatially restricted domains including limb muscle, neural tube and neural crest. Evidence for its crucial role in morphogenesis and organogenesis is provided by rodent mutants and human diseases (reviewed in Mansouri et al., 1996) . Loss-of-function mutations in the Pax3 gene are responsible for the Splotch phenotype in mice (Epstein et al., 1991) and the Waardenburg syndrome in humans (Baldwin et al., 1992; Tassabehji et al., 1992) in which development defects in limb muscle and neural crest derivatives occur. Several Pax gene products, including Pax3, have been shown to induce both transformation of cells in culture and tumors in nude mice (Maulbecker and Gruss, 1993) . Furthermore, a t(2;13) chromosomal translocation juxtaposing the amino-terminal DNA-binding domains of Pax3 with the transcriptional activation domain of FKHR (a Forkhead family member) results in a fusion protein that is a more potent transcriptional activator than Pax3 itself (Fredericks et al., 1995) and causes pediatric alveolar rhabdomyosarcoma Galili et al., 1993; Shapiro et al., 1993) Three proteins that interact with the homeodomain of Pax3 have been recently identi®ed. The retinoblastoma protein (pRB) was demonstrated to down-regulate Pax3 transcriptional activity via a direct interaction with the homeodomain (Wiggan et al., 1998) . HIRA, a mammalian homologue of a Saccharomyces Cerevisae transcriptional co-repressor, was shown to associate with the Pax3 homeodomain (Magnaghi et al., 1998) . More recently, the Daxx protein was demonstrated to interact with Pax3 both in vitro and in vivo (Hollenbach et al., 1999) . While Daxx eciently represses the transcriptional activity of Pax3 through this interaction, the Pax3-FKHR fusion protein does not respond to the repressive eect of Daxx. Such a deregulation in the transcriptional control may partly account for the oncogenic properties of Pax3-FKHR (Hollenbach et al., 1999) . The Daxx protein was originally characterized as an adaptator molecule that binds the death domain of Fas , triggering activation of the Jun N-terminal kinase (JNK) pathway (Chang et al., 1998) . Daxx was then identi®ed as an interacting partner for several other proteins apparently unrelated to the Fas pathway. In addition to Pax3, it was shown to interact with the centromeric protein CENP-C (Pluta et al., 1998) and the DNA methyltransferase I (Michaelson et al., 1999) . Daxx also reportedly binds a steroidogenic factor 1-like DNA element (Kiriakidou et al., 1997) . Very recently, Daxx has been found to associate (Li et al., 2000) and colocalize (Ishov et al., 1999; Li et al., 2000; Torii et al., 1999) with the tumor suppressor PML protein in the so-called PML nuclear bodies (NBs).
These structures appear as dense spherical particles that are tightly associated with the nuclear matrix. Although various functions have been attributed to these nuclear domains including apoptosis, viral infection and transcriptional control, their exact function remains unknown (for review see Seeler and Dejean, 1999; Zhong et al., 2000b) . In acute promyelocytic leukemia (APL), the PML gene is fused to the retinoic acid receptor a (RARa) gene as a result of the t(15;17) chromosomal translocation, giving rise to the PML-RARa fusion oncoprotein (De TheÂ et al., 1990; Kakizuka et al., 1991) . Expression of PML-RARa leads to the disruption of the NBs in APL cells. Treatment of APL patients with retinoic acid can induce complete remissions and, in the APL blasts, retinoic acid induces the restoration of intact NBs (Dyck et al., 1994; Koken et al., 1994; Weis et al., 1994) . Arsenic trioxide (As 2 O 3 ), an antileukemic drug used in Chinese traditional medicine, has also proven to be eective in the treatment of APL, including RAresistant leukemias (Shen et al., 1997) . Treatment by As 2 O 3 increases the size of the NBs in normal cells and induces the recruitment of PML to these structures in association with its covalent modi®cation with the ubiquitin-like modi®er SUMO-1 (Kamitani et al., 1998; MuÈ ller et al., 1998; Sternsdorf et al., 1997) . Finally, it has been reported that treatment by interferons (IFNs) strongly upregulates the transcription of the PML gene, leading to a signi®cant increase in both size and number of the NBs (Guldner et al., 1992; Lavau et al., 1995; Stadler et al., 1995) .
Here we show that the Daxx-mediated repression of Pax3 transcriptional activity can be inhibited by PML. Interestingly, this inhibition correlates with the recruitment of Daxx to the NBs. Factors that trigger the targeting of Daxx to the NBs such as arsenicals and interferons, also suppress the repressive eect of Daxx on Pax3. By contrast, disruption of the NBs caused either by the expression of PML-RARa or by the lack of PML expression enhances the repressive eect of Daxx on Pax3. Moreover, a PML mutant that can not undergo modi®cation by SUMO-1 is defective in reversing Daxx repressing activity on Pax3 and fails to recruit Daxx into the NBs. Altogether, these results suggest that SUMO-1 modi®ed PML activates Pax3-dependent transactivation by preventing the access of Daxx to Pax3 target genes through recruitment of Daxx to the NBs. They provide the ®rst molecular evidence for a role of these structures in the regulation of transcriptional repression.
Results

PML inhibits Daxx-mediated repression of Pax3 transcriptional activity through sequestration of Daxx in the NBs
It has been shown previously that Daxx can localize both at condensed chromatin and in the PML NBs (Ishov et al., 1999; Li et al., 2000) . In an attempt to clarify the relationship between Daxx localization and its repressive properties on Pax3, we wished to analyse the eect of PML on Daxx-mediated repression. NIH3T3 cells were transiently transfected with a combination of expression vectors encoding Pax3, Daxx and PML together with the reporter construct (PRS-9)TK-CAT, which contains both Pax3 paired and homeodomain recognition sequences (Chalepakis et al., 1994) . Consistent with previous ®ndings, expression of Daxx partially inhibits Pax3 transactivation (40% repression, Figure 1a , compare lane 2 to 3), although, in our case, the level of repression was repeatedly lower than that reported before (Hollenbach et al., 1999) . Interestingly, coexpression of PML together with Daxx and Pax3 restores the Pax3 activation level (Figure 1a , lane 4), indicating that PML can reverse Daxx-mediated transcriptional repression. When PML was expressed along with Pax3 in the absence of Daxx, a slightly stronger activation of the reporter was reproducibly visible (Figure 1a , lane 5), an observation that could be attributable to the ability of PML to relieve the repressing eect of endogenous Daxx. We then analysed the action of PML on the fusion Pax3-FKHR oncoprotein which had been shown to be unresponsive to the inhibitory eect of Daxx (Hollenbach et al., 1999) . Consistent with previous ®ndings, when Pax3-FKHR was substituted for Pax3 in an identical transcriptional assay. Daxx was unable to repress the Pax3-FKHR transcriptional activity (Figure 1a , compare lane 7 to 6). Coexpression of PML with Pax3-FKHR alone or with Pax3-FKHR together with Daxx had no eect on the reporter activity ( Figure 1a , lanes 8 and 9). These data suggest that PML regulates the transactivation properties of Pax3 in a Daxx-dependent manner.
To get further inside the process by which PML inhibits Daxx-mediated repression on Pax3, we performed double immuno¯uorescence experiments in NIH3T3 cells transfected with vectors encoding Daxx or an HA-tagged Pax3 (HA-Pax3) with or without PML. As shown in Figure 1b , HA-Pax3 was diusely distributed throughout the nucleus in all transfected cells (panel A) with no evidence for accumulation in the NBs as visualized using an antibody against endogenous PML (panels B and C). Cotransfection of PML along with HA-Pax3 did not aect the diuse nuclear distribution of HA-Pax3 though, as reported before, a dramatic increase in the size of the NBs was noted (panels D to F). When Daxx alone was overexpressed, it adopted a nuclear diuse distribution in most of the transfected cells (panel G). A few cells, corresponding to the lower expressing ones, showed an accumulation of Daxx in nuclear dots (panel G, right lower cell) which, for most of them, corresponded to the NBs (panels H and I). Interestingly, upon coexpression of PML, the diuse fraction of ectopically expressed Daxx became hardly detectable and nearly all of the protein was recruited to the NBs, (panels J to L). At high expression level, Daxx still exhibited a nuclear diuse distribution albeit in a smaller percentage of cells, as well as an accumulation in large aggregates together with PML (panels J to L, upper cell). Taken together, the transactivation and immuno¯uorescence data strongly suggest that PML inhibits the Daxx repressive eect on Pax3 activity by diverting Daxx from the natural Pax3 target genes to the NBs. drastically increase the expression of PML at the transcriptional level (Guldner et al., 1992; Lavau et al., 1995; Stadler et al., 1995) whereas As 2 O 3 promotes the post-translational modi®cation of PML by the SUMO-1 modi®er, which in turn is recruited to the NBs (Kamitani et al., 1998; MuÈ ller et al., 1998; Sternsdorf et al., 1997) . We therefore wished to analyse the eect of IFNs and As 2 O 3 on Daxx repression and localization. NIH3T3 cells transfected with expression vectors for Pax3 alone or Pax3 and Daxx were treated for 12 h by After 24 h, CAT activity was determined as described (Ausubel et al., 1996) . All values were normalized for co-transfected b-galactosidase (b-Gal) activity and are presented relative to the activity exhibited by cells transfected with Pax3 alone. Error bars represent the standard deviation from three independent determinations. (b) PML overexpression induces the recruitment of Daxx but not that of Pax3 to the NBs. NIH3T3 cells were transfected with plasmid constructs expressing either HA-Pax3 alone (A ± C), HA-Pax3 and PML (D ± F), Daxx (G ± I), Daxx and PML (J ± L) or Daxx and PML-3M (M ± O) as indicated. The antibodies used were the 12CA5 mAb against the HA tag of Pax3, a rabbit polyclonal against PML that cross reacts with mouse PML (Borden et al., 1995) (Borden et al., 1995) and the M112 anti-Daxx mAb. Labeling was performed on untreated cells, panels A to C, cells treated for 12 h with 1 mM As 2 O 3 , panels D to F, or cells treated for 12 h with 200 U/ml IFNa, panels G to I. The staining pattern was analysed by confocal laser microscopy. The red signal (PML) is obtained with an anti-rabbit Ig Texas red-conjugated secondary antibody, the green signal (Daxx) with an anti-mouse Ig¯uorescein-conjugated secondary antibody. Superimposing the two colors (merge) results in a yellow signal, where both proteins co-localize Figure 2b . In the absence of any treatment, PML mainly concentrates in the NBs (panel B) whereas Daxx shows a nuclear diuse distribution with some accumulation in speckles (panel A) a subset of which corresponds to the NBs (panel C). Treatment with As 2 O 3 induces the characteristic redistribution of the nucleoplasmic PML protein to the NBs, that consequently enlarge and form fewer and larger speckles, (panel E). Immunostaining of As 2 O 3 -treated cells revealed a signi®cant recruitment of Daxx to these enlarged NBs while the diuse fraction diminished simultaneously (panels D to F). Similarly, IFNa treatment induces, in almost every cell, an important relocalization of Daxx to multiple nuclear speckles corresponding to the anti-PML stained NBs (panels G to I). Together, the data of transcriptional activity and localization indicate that Daxx is recruited to the NBs by treatment with As 2 O 3 and IFNa, correlating with derepression of Pax3 transcriptional activity.
NB disruption is associated with impaired Pax3 transcriptional activity
The ®ndings described above indicate that the recruitment of Daxx to the NBs correlates with inhibition of its repressive properties on Pax3 activity. We thus speculated that the destruction of the NBs should, on the opposite, be associated with an enhanced Daxx-mediated repressive eect on Pax3 activation. To address this question, we ®rst studied the eect of the PML-RARa oncoprotein, that had been shown to disrupt the NBs into numerous aberrant microstructures (Dyck et al., 1994; Koken et al., 1994; Weis et al., 1994) , on the (PRS-9) TK-CAT reporter construct in cotransfected NIH3T3 cells (Figure 3) . As expected, expression of PML-RARa resulted in a notable decrease in the transcriptional activity of Pax3 and this eect could be seen either in the absence of exogenous Daxx (compare lane 5 to 2) or in its presence (compare lane 4 to 3). Therefore we were interested in analysing the subcellular distribution of Daxx upon coexpression of PML-RARa (Figure 3b ). Double labeling of NIH3T3 cells cotransfected with PML-RARa and Daxx showed the typical microparticulate PML staining characteristic of the PML-RARa microstructures. Instead, Daxx was dispersed throughout the nucleus although some colocalization of Daxx and PML-RARa was still hardly detectable. These data favor the hypothesis that, by contrast to PML that recruits Daxx to the NBs, PMLRARa, by disrupting these structures, leads to the release of Daxx to the nucleoplasm, thus increasing its overall repression activity.
We and others had shown previously that in PML7/ 7 cells, that do not contain any PML nuclear bodies, Daxx is detected in a diuse or condensed chromatinassociated patched pattern in the nucleus (Ishov et al., 1999; Zhong et al., 2000a) . We thus sought to determine whether Pax3-dependent transactivation was impaired in the absence of NBs. PML+/+ and PML7/7 MEFs were transfected with the reporter construct (PRS-9)TK-CAT in the absence or presence of Pax3. As shown in Figure 3c , Pax3 stimulated the reporter gene activity in PML+/+ MEFs by up to 30-fold, whereas in PML7/ 7 MEFs, Pax3-dependent transactivation was dramatically reduced (threefold induction). The level of expression of transfected Pax3 protein was comparable in both cell types, as determined by Western analysis (data not shown). Thus, in the absence of PML and its associated NBs, Pax3 transcriptional activity is signi®cantly reduced. These data are consistent with the interpretation that the repressive eect of Daxx is likely to be carried out outside the NBs in the chromatin compartment.
SUMO-1 modification of PML is necessary for relief of Daxx-mediated repression and for sequestration of Daxx into the NBs
The recent ®nding that SUMO-1 modi®cation of PML is required for its proper targeting to the NBs (MuÈ ller et al., 1998; Zhong et al., 2000a) led us to hypothesize that modi®cation by SUMO-1 may regulate the ability of PML to inhibit Daxx-mediated repression of Pax3 activity. To address this point, we studied the properties of a PML mutant (PML-3M) that is no longer SUMO-1 modi®ed due to mutations of all three SUMO-1 modi®cation lysine residues (Zhong et al., 2000a) , and to do so, we used an identical transient transcription assay as for PML. As shown in Figure 4a , we found that this SUMO-1 de®cient mutant, unlike PML, is unable to relieve the repressive eect of both exogenous (compare lane 5 to 4) and endogenous Daxx (compare lane 7 to 6) on Pax3 transcriptional activity.
To then determine whether the modi®cation state of PML may modulate the recruitment of Daxx into the NBs, we cotransfected NIH3T3 cells with Daxx and PML-3M and performed immuno¯uorescence analysis. While the PML-3M mutant was found to accumulate into two to three aberrant nuclear aggregates per cell (Figure 1b, panel N) , Daxx was mainly diuse or in patches in the nucleus with no evidence for accumulation into the large PML-3M aggregates (Figure 1b , panels M to O). Thus, the SUMO-1 de®cient PML mutant fails to recruit Daxx into the NBs. Interestingly, in a few cells, we could observe the presence of Daxx at the center of the PML-3M aggregates Oncogene Pax3 regulation by Sumoylated PML F Lehembre et al suggesting that a fraction of the mutant protein accumulates on pre-existing NBs (data not shown).
An interaction between PML and Daxx has been reported using a yeast two-hybrid assay (Ishov et al., 1999; Li et al., 2000) . Given that PML-3M fails both to reverse the Daxx repressing eect on Pax3 activity and to induce Daxx relocalization to the NBs, we next wish to examine whether such a mutant could still interact with Daxx in a yeast two-hybrid test. In this assay, the threshold of HIS3 reporter gene activity required for growth of cotransformants in histidine deprived medium can be arti®cially increased by addition of 3-aminotriazole (3-AT), providing a semi-quantitative assay for protein ± protein interaction. When coexpressed with Daxx, PML is able to support growth in medium lacking histidine supplemented with 20 mM 3-AT (Figure 4b , lane c) con®rming the strong interaction between PML and Daxx. In contrast, PML-3M fails to interact with Daxx, as shown by the incapacity of the co-transformants to grow in medium lacking histidine supplemented with 3-AT ( Figure 4b, lane d) . All the proteins were expressed at equal level as judged by Western blotting (data not shown).
Taken together, these data indicate that conjugation to SUMO-1 is a prerequisite for PML to interact with and sequester Daxx in the NBs as well as for inhibiting the transcriptional repression of Daxx on Pax3 activity.
Discussion
In the present work, we have shown that Pax3 transcriptional activation can be modulated by the NB-associated PML protein. Expression of PML activates Pax3 transactivation through inhibition of the repressive eect of Daxx which, in turn, correlates with its accumulation in the NBs. One may hypothesize that retention of Daxx into these subnuclear structures through overexpression of PML or treatment with IFNa or As 2 O 3 would prevent its access to Pax3 responsive genes and consequently impede its repressive action. In contrast, in situations where NB integrity is compromised, Pax3 transcriptional activity is dramatically reduced, an eect which may be due to the observed relocalization of Daxx from the NBs to the nucleoplasm in these conditions. Thus, these ®ndings raise the interesting possibility that the PML NBs may play a role in Pax3 transcriptional control.
The NBs have been proposed to enhance gene expression through recruitment of activators. For example, transcriptional activators like TIF1a, the progesterone receptor and p53 were found associated with the NBs (Zhong et al., 2000b and references therein) . However, the precise mechanism underlying this activator role remains unknown. Subnuclear compartments that function to concentrate regulatory factors and complexes may be important in modulating gene expression (Schul et al., 1998) . For example, the interchromatin granul cluster is able to concentrate transcriptional coactivators in the protein rich core, and is surrounded by transcriptionally active chromatin (Hendzel et al., 1998) . Similarly, a recent study has shown that although NBs contain neither chromatin nor RNA, nascent RNA can be detected at their periphery. Thus, if the NBs are not sites of transcription, their surroundings may create a favorable environment for gene expression (Boisvert et al., 2000) .
Alternatively, NBs may participate to the transcriptional activation of speci®c target genes by titering out corepressors from the diuse nuclear fraction, where transcription takes place. Indeed, the fact that Daxx concentrates at condensed chromatin in PML7/7 cells (Ishov et al., 1999) supports the idea that Daxx is likely to exert its repressive properties outside the NBs. We propose that regulation of Daxx localization may represent a mechanism whereby the activity of the Pax3 transactivator is modulated. Interestingly, it has been reported that pRB is able to repress Pax3 transcriptional activity through a direct interaction with the Pax3 homeodomain (Wiggan et al., 1998) . Moreover, Alcalay et al. (1998) have demonstrated that pRB accumulates in the NBs and that PML can abolish pRB activation of glucocorticoid receptor-mediated transcription. In light of these observations, it would be interesting to determine whether PML can similarly act on pRBdependent repression of Pax3 via a sequestration of pRB in the NBs. While this manuscript was in preparation, Li et al. (2000) reported that PML can sequester a Gal4-Daxx fusion protein in the NBs thus inhibiting its repressive properties. Furthermore, we have previously shown that another major component of the NBs, the SP100 protein, is able to interact with and recruit the HP1 repressor into these structures (Seeler et al., 1998) . Similarly, Tax repressor function was shown to be inactivated when recruited into the NBs (Doucas and . Altogether, these data suggest that the PML NBs may function as a reservoir that regulates the equilibrium between NB-and chromatin-associated repressors thus providing a new mechanism for transcriptional control involving subnuclear compartmentalization.
Another main feature of this study is the demonstration that the post-translational modi®cation of PML by the ubiquitin-related protein SUMO-1 is critical for mediating PML-Daxx interactions and for recruiting Daxx to the NBs with concomitant inhibition of its repressor function. Therefore, the regulation of PML modi®cation by SUMO-1 may be a critical step in Pax3 transactivation control. Whether titration of corepressors by SUMO-1 modi®ed PML is a general phenomenon remains to be investigated. Although the precise role of the SUMO-1 conjugation pathway is still unclear (for review, see Jentsch and Pyrowolakis, 2000; Yeh et al., 2000) , it does not seem to promote protein degradation. It has been shown previously to be implicated, at least in some cases, in protein ± protein interaction. The ®rst identi®ed substrate of SUMO-1, the RanGAP1 protein, was found to interact with RanBP2 upon SUMO-1 modi®cation thus correlating with its recruitment to the nuclear pore complex (Mahajan et al., 1997; Matunis et al., 1996) . Thus SUMO-1 modi®cation might play an important Pax3 regulation by Sumoylated PML F Lehembre et al role in regulating the sub-cellular compartmentalization of speci®c protein substrates. Another role for SUMO-1 modi®cation as a mechanism antagonizing ubiquitination has been proposed recently. The IkBa inhibitor was reported to be modi®ed by SUMO-1 at the same lysine residue as the one used for ubiquitination, thus protecting IkBa from degradation (Desterro et al., 1998) . Numerous SUMO-1 targets have been identi®ed in recent years and one may expect the existence of multiple cellular functions for this modi®cation process. The recent characterization of the dierent enzymes involved in SUMO-1 modi®ca-tion and demodi®cation should help, through loss and/ or gain of function studies, in clarifying this issue. 
Materials and methods
Transient transfections and CAT assays
NIH3T3 cells and Murine Embryo Fibroblasts (MEFs) were plated in 6-well dishes and transfected the following day by the lipofectAMINE TM method (Gibco-BRL), according to the manufacturer's speci®cations. The lipofectamine TM /DNA precipitates consisted of 100 ng of pcDNA3-Pax3, 100 ng of pcDNA3-Pax3-FKHR, 500 ng of pcDNA3-Daxx, 1 mg of PSG5-PML or PSG5-PML-3M or PSG5-PML-RARa, 1 mg of the (PRS-9)TK-CAT reporter plasmid, containing the Pax3 paired and homeodomain recognition sequences, and 500 ng of pCMVb-Gal control plasmid. Analysis of CAT activity was performed as described (Ausubel et al., 1996) , quanti®ed by PhosphorImager analysis (IMAGEQUANT) of thin-layer chromatograms and normalized for transfection eciency by using pCMVb-Gal and measuring b-galactosidase activity. Each experiment was repeated twice in triplicate plates. As 2 O 3 was prepared as a 1 mM stock solution in phosphate-buered saline (PBS). The working concentration for As 2 O 3 was 1 mM and mouse IFNa was used at a ®nal concentration of 200 U/ml.
Antibodies
The rabbit polyclonal antibody against the human PML that cross-reacts with the mouse PML was a generous gift of Paul Freemont (Borden et al., 1995) . The anti-PML monoclonal antibody (MAb) 5E10 was described previously (Stuurman et al., 1992) . The rabbit polyclonal anti-Daxx and anti-Pax3 antibodies have been described before (Hollenbach et al., 1999) . The monoclonal M112 anti-Daxx antibody was purchased from Santa-Cruz Biotechnology. MAb 12CA5 (Boehringer Mannheim) was used against the HA tag. The monoclonal anti-FLAG antibody (M2) was purchased from Sigma.
Indirect immunofluorescence and confocal laser microscopy
For immuno¯uorescence, NIH3T3 cells were grown on round coverslips in 6-well plates. Cells were ®xed in 3.7% paraformaldehyde in PBS for 10 min at room temperature, and then permeabilized with 0.5% Triton X-100 in PBS for 15 min at room temperature. After ®xation and permeabilization, cells were rinsed twice in PBS and once in PBS containing 0.05% Tween-20 (PBS-Tw), incubated with primary antibodies for 1 h, washed in PBS and PBS-Tw, and further incubated with the appropriate secondary antibodies conjugated with either¯uorescein (Sigma) or Texas red (Amersham). Primary and secondary antibodies were used at a dilution of 1 : 200 except for the anti-PML MAb 5E10 (1 : 2). After three washes in PBS, the samples were mounted in Vectashield (Vector Laboratories, Burlington, CA, USA). Confocal laser scannning microscopy was performed with a LEICA SM microscope, using excitation wavelengths of 488 nm (for¯uorescein) and 543 nm (for Texas red). The two channels were recorded independently and pseudocolor images were generated and superimposed. The acquired digital images were processed using Adobe Photoshop v5.0 software.
Two-hybrid assays
The interaction between Daxx and PML or PML-3M was determined in a yeast two-hybrid assay using HIS3 activity as a reporter of protein ± protein interaction. PML and PML-3M were cloned in pAS1 vector that contains the TRP1 gene, so that the protein are fused to the GAL4-DBD. Daxx, cloned in pVP16 which carries the LEU2 gene, was a gift from Alexander Ishov. Plasmids were transfected in the Y187/CG1945 diploid yeast strain (CLONTECH). Yeast cells were streaked on plates lacking leucine and tryptophane (-LW) or lacking leucine, tryptophane and histidine (-LWH) supplemented with various concentrations of 3-aminotriazole (3-AT). Growth was monitored after 3 to 5 days incubation at 308C. Figure 4 Modi®cation of PML by SUMO-1 is required for reversing Daxx-mediated repression on Pax3 and for mediating Daxx-PML interaction. (a) PML-3M is unable to relieve Daxxmediated repression. CAT assay analysis was performed as described in Figure 1 using the (PRS-9)TK-CAT construct as a reporter. (b) Daxx is no more able to interact with PML-3M in a yeast two-hybrid test. PML and PML-3M were used as bait proteins and assayed for interaction with Daxx prey protein using HIS3 gene reporter. Yeast double transformants were plated on the indicated medium. H: histidine, 3-AT: 3-aminotriazole and for providing reagents. This work was supported by grants from the Association pour la Recherche contre le Cancer, the European Economic Community (Biomed 2, PCRD), and the Association for International Cancer Research. F Lehembre was supported by a fellowship from la Fondation pour la Recherche Medicale. S MuÈ ller was supported by a fellowship from the Association for International Cancer Research.
